Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05541679 · ClinicalTrials.gov registry record · NA
Comparison of Left Bundle Branch Area Versus Right Ventricular Septal Pacing in Patients With High-degree Conduction Disease After Transcatheter Aortic Valve Replacement (Left Bundle BRAVE)
A NA study of Aortic Valve Stenosis and Complete Heart Block, sponsored by Main Line Health.
- Active
- Registry status
- NA
- Development phase
- 46
- Enrollment target
- 4
- Study locations
NCT05541679 is a NA study of Aortic Valve Stenosis and Complete Heart Block that is active but no longer recruiting, run by Main Line Health. The registered enrollment target is 46 participants, below the 1,042-participant average among 30 other Aortic Valve Stenosis trials with a reported enrollment target (96% lower). The trial reports 4 study locations across 3 states.
The verdict
NCT05541679, a NA study of Aortic Valve Stenosis and Complete Heart Block, is active but no longer recruiting, sponsored by Main Line Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of the study is to investigate the superiority of chronic left bundle branch area pacing compared to traditional right ventricular (RV) septal pacing in patients with high-grade conduction disease after transcatheter aortic valve replacement (TAVR). In this investigator initiated, multicenter, prospective, double-blinded, crossover study, chronic left bundle branch area pacing will be compared to chronic right ventricular septal pacing using echocardiographic measures of left ventricular systolic function in patients with a high cumulative ventricular pacing burden after TAVR.
Conditions Studied
Interventions
- DEVICE Right ventricular septal pacing followed by left bundle branch area pacing
- DEVICE Left bundle branch area pacing followed by right ventricular septal pacing
Study Locations (4)
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
- Lankenau Medical Center - Wynnewood
Kansas
- Kansas City Heart Rhythm Institute - Overland Park
New Jersey
- Valley Health System - Ridgewood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2022-12-28 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05541679
The ClinicalTrials.gov registry entry for NCT05541679 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,042-participant average among 30 other Aortic Valve Stenosis trials with a reported enrollment target (96% lower). The listed sponsor is Main Line Health, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Aortic Valve Stenosis appearing as the primary indexed condition, and to 2 interventions - of which Right ventricular septal pacing followed by left bundle branch area pacing is the first listed.
NCT05541679 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Pennsylvania, Kansas, New Jersey.
Frequently Asked Questions
What is clinical trial NCT05541679 about?
NCT05541679 is a clinical study titled "Comparison of Left Bundle Branch Area Versus Right Ventricular Septal Pacing in Patients With High-degree Conduction Disease After Transcatheter Aortic Valve Replacement (Left Bundle BRAVE)". The purpose of the study is to investigate the superiority of chronic left bundle branch area pacing compared to traditional right ventricular (RV) septal pacing in patients with high-grade conduction disease after transcatheter aortic valve replacement (TAVR). In this investigator initiated, multic...
What is the current status of trial NCT05541679?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 46 participants. The study started on 2022-12-28. Estimated completion is 2025-12-31.
What conditions does trial NCT05541679 study?
This clinical trial studies the following conditions: Aortic Valve Stenosis, Complete Heart Block, High Degree Second Degree Atrioventricular Block, Pacemaker-Induced Cardiomyopathy.
What interventions are being tested in trial NCT05541679?
The interventions under investigation include: Right ventricular septal pacing followed by left bundle branch area pacing (DEVICE), Left bundle branch area pacing followed by right ventricular septal pacing (DEVICE).
Who is sponsoring clinical trial NCT05541679?
This trial is sponsored by Main Line Health, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05541679 being conducted?
This trial has 4 study locations across Kansas, New Jersey, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Valve Stenosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Imaging Histone Deacetylase in the Heart
RECRUITING · NA
-
MRI in Transcatheter Aortic Valve Replacement Patients
RECRUITING · NA
-
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
RECRUITING · NA
-
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
RECRUITING · NA
-
Bicuspid Aortic Valve Replacement: Evaluation of Transcatheter Versus Surgery-Pilot Trial
RECRUITING · NA
-
CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.